Targeted therapies in gynecological cancers: a comprehensive review of clinical evidence

被引：103
作者：
Wang, Qiao [1 ]
Peng, Hongling [1 ]
Qi, Xiaorong [1 ]
Wu, Min [2 ]
Zhao, Xia [1 ]
机构：
[1] Sichuan Univ, Key Lab Birth Defects & Related Dis Women & Child, West China Hosp 2,Dept Gynecol & Obstet,Minist Ed, Dev & Related Dis Women & Children Key Lab Sichua, Chengdu 610041, Sichuan, Peoples R China
[2] Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, Grand Forks, ND 58203 USA
来源：
SIGNAL TRANSDUCTION AND TARGETED THERAPY | 2020年 / 5卷 / 01期
关键词：
PHASE-II TRIAL; RECURRENT EPITHELIAL OVARIAN; PLATINUM-RESISTANT OVARIAN; PRIMARY PERITONEAL CARCINOMA; ANTIBODY-DRUG CONJUGATE; POLY(ADP-RIBOSE) POLYMERASE INHIBITOR; PERSISTENT ENDOMETRIAL CANCER; MIRVETUXIMAB SORAVTANSINE IMGN853; PEGYLATED LIPOSOMAL DOXORUBICIN; SQUAMOUS-CELL-CARCINOMA;
D O I：
10.1038/s41392-020-0199-6
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Advanced and recurrent gynecological cancers are associated with poor prognosis and lack of effective treatment. The developments of the molecular mechanisms on cancer progression provide insight into novel targeted therapies, which are emerging as groundbreaking and promising cancer treatment strategies. In gynecologic malignancies, potential therapeutic targeted agents include antiangiogenic agents, poly (ADP-ribose) polymerase (PARP) inhibitors, tumor-intrinsic signaling pathway inhibitors, selective estrogen receptor downregulators, and immune checkpoint inhibitors. In this article, we provide a comprehensive review of the clinical evidence of targeted agents in gynecological cancers and discuss the future implication.
引用
收藏
页数：34
相关论文
共 50 条
  • [21] Molecularly targeted therapies in cervical cancer. A systematic review
    Zagouri, Flora
    Sergentanis, Theodoros N.
    Chrysikos, Dimosthenis
    Filipits, Martin
    Bartsch, Rupert
    [J]. GYNECOLOGIC ONCOLOGY, 2012, 126 (02) : 291 - 303
  • [22] HER2-targeted therapies in cancer: a systematic review
    Zhu, Kunrui
    Yang, Xinyi
    Tai, Hebei
    Zhong, Xiaorong
    Luo, Ting
    Zheng, Hong
    [J]. BIOMARKER RESEARCH, 2024, 12 (01)
  • [23] Chemotherapy and targeted therapies for meningiomas: what is the evidence?
    Graillon, Thomas
    Tabouret, Emeline
    Chinot, Olivier
    [J]. CURRENT OPINION IN NEUROLOGY, 2021, 34 (06) : 857 - 867
  • [24] Targeted anti-vascular therapies for ovarian cancer: current evidence
    Hall, M.
    Gourley, C.
    McNeish, I.
    Ledermann, J.
    Gore, M.
    Jayson, G.
    Perren, T.
    Rustin, G.
    Kaye, S.
    [J]. BRITISH JOURNAL OF CANCER, 2013, 108 (02) : 250 - 258
  • [25] Imaging in oral cancers: A comprehensive review
    Mahajan, Abhishek
    Ahuja, Ankita
    Sable, Nilesh
    Stambuk, Hilda E.
    [J]. ORAL ONCOLOGY, 2020, 104
  • [26] Combining molecular targeted therapies: clinical experience
    Pivot, Xavier
    Bedairia, Nadia
    Thiery-Vuillemin, Antoine
    Espie, Marc
    Marty, Michel
    [J]. ANTI-CANCER DRUGS, 2011, 22 (08) : 701 - 710
  • [27] Emerging targeted therapies for melanoma treatment (Review)
    Russo, Angela
    Ficili, Bartolomea
    Candido, Saverio
    Pezzino, Franca Maria
    Guarneri, Claudio
    Biondi, Antonio
    Travali, Salvatore
    McCubrey, James A.
    Spandidos, Demetrios A.
    Libra, Massimo
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (02) : 516 - 524
  • [28] Evidence for Therapeutic Drug Monitoring of Targeted Anticancer Therapies
    Gao, Bo
    Yeap, Shang
    Clements, Arthur
    Balakrishnar, Bavanthi
    Wong, Mark
    Gurney, Howard
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (32) : 4017 - 4025
  • [29] Emerging therapies for rare cutaneous cancers: A systematic review
    Garcia, Andrew
    Nelson, Kamaria
    Patel, Vishal
    [J]. CANCER TREATMENT REVIEWS, 2021, 100
  • [30] Understanding the HPV associated cancers: A comprehensive review
    Balhara, Nikita
    Yadav, Ritu
    Ranga, Shalu
    Ahuja, Parul
    Tanwar, Mukesh
    [J]. MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
12345